As mentioned previously, elevated ROS is a hallmark of IDH-mutated malignancies.53,89,90 An imaging study demonstrated that levels of glutamate, glutamine and glutathione are decreased in tumour regions in patients with IDH-mutated glioma, as compared with levels in contralateral regions. This evidence concerns the gene IDH1 and central nervous system cancer.